Group 1 - The core viewpoint of the news is the performance and holdings of the China Europe Medical Health Mixed Fund C, which has shown significant growth in recent months and year-to-date [1] - As of August 21, 2025, the latest net value of the fund is 1.8954 yuan, reflecting a growth of 0.78% [1] - The fund's one-month return is 5.63%, three-month return is 20.86%, and year-to-date return is 25.65%, with respective rankings of 4196 out of 4701, 1241 out of 4632, and 1624 out of 4492 [1] Group 2 - The top ten stock holdings of the fund account for a total of 54.73%, with major positions in WuXi AppTec (10.39%), Hengrui Medicine (9.69%), and Kanglong Chemical (5.05%) [1] - The fund was established on September 29, 2016, and as of June 30, 2025, it has a total scale of 15.163 billion yuan [1] - The fund is managed by two managers: Ge Lan and Zhao Lei, with Ge Lan having a background in biomedical engineering and extensive experience in fund management [2]
8月21日中欧医疗健康混合C净值增长0.78%，今年来累计上涨25.65%
Sou Hu Cai Jing·2025-08-21 12:19